The Director for Drug Substance Commercialization of Polysaccharides leads assigned commercialization workstreams and facilitates launch readiness and commercial supply of polysaccharides used in glycoconjugate vaccines. The role focuses on technical launch planning and execution, coordinating cross-functional efforts for regulatory filings, facility readiness, and launch supplies. It also ensures the organization can communicate the scientific and commercial rationale for critical raw material manufacturing processes to internal stakeholders, contract manufacturing organizations (CMOs), and regulatory agencies, and supports timely planning and execution of commercial lifecycle management. Reporting to the Senior Director for Global Polysaccharide Commercialization, the Director collaborates on overall program strategy and is primarily accountable for the polysaccharide component strategy. Within Manufacturing Science and Technology (MSAT), the role supports the transition of vaccine processes from Process Development to Commercial, technical launch and commercialization strategy, and process robustness throughout the product lifecycle. MSAT provides technical and process support for end-to-end commercial manufacturing across polysaccharides, carrier proteins, and conjugation, including technology transfer, process characterization for validation, process improvement, evaluation of new technologies, and investigation of manufacturing issues. The position is remote in the United States and requires 10–30% travel. The listed salary range is $223,000–$261,000 for the San Francisco Bay Area; ranges for non-California locations may vary. The compensation package includes comprehensive benefits and an equity component. Relocation assistance is not available.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Job Type
Full-time
Career Level
Director